Countdown to Dermatology Masterclass
The conference’s course directors will provide a sneak peek at what in-person and virtual attendees will learn about AI, alternative medicine, surgical management of HS, and more.
French Dermatology Times: La Roche-Posay products recommended by dermatologists for eczema and acne
Dermatologists Janine Downey, Diane Davis and Hope Mitchell unveiled the La Roche-Posay products they recommend for patients with dry skin, eczema and more at the company’s flagship store in France.
Gain access to Roflumilastform and Kabutreo in 2024
Shanna Miranti of Pennsylvania MPAS shares an update on the status of Roflumilast Foam 0.3% and Kabutreo available in U.S. pharmacies.
On-site skin cancer screening promotes awareness and early detection
The Skin Cancer Foundation’s initiative, Destination Healthy Skin, travels in RVs to cities across the country, where volunteer dermatologists perform free skin exams on the street.
National Rosacea Association launches Seal of Acceptance Program
NRS, in collaboration with dermatology experts, recently developed a Seal of Approval for clinically tested and evaluated skin care and cosmetic products for rosacea patients.
Dr. Mike Siegel: What will happen to PeDRA in 2024?
In an interview with Dermatology Times, the executive director of the Pediatric Dermatology Research Alliance (PeDRA) discussed the group’s growth since 2012 and what it can offer practicing dermatologists, researchers, students, and patients. I’ll talk about it.
A sneak peek at Dermatology’s 2024 Masterclass with Alice Gottlieb, M.D., Ph.D.
Learn what makes Dermatology Conference Masterclasses a unique educational opportunity and take a quick survey to tell us what you want to learn.
Advances in psoriasis treatment
Alice Gottlieb, MD, focuses on recent research and current psoriasis treatment tools that dermatologists should consider.
AI is transforming healthcare: Insights from gastroenterology to dermatology
The transformative impact of AI on healthcare explored by Dr. Ryan Stidham reveals potential applications in dermatology and highlights the need for caution, ethical considerations, and cross-disciplinary collaboration.
Thoughts on Cutaneous Lupus by Joseph Merola, MD, MMSc
Learn about the evolving landscape of lupus treatment, from the importance of monitoring vitamin D levels to advances in new treatments targeting type 1 interferon and plasmacytoid dendritic cells.
Addressing the challenges of dermatologic surgery
Dr. Daniel Siegel shared strategies for managing surgical challenges, especially bleeding, to provide a smooth experience for patients.
Navigating pregnancy, dermatology, and drug safety
Katherine Economy, MD, discusses the challenges and opportunities of treating pregnant patients with skin diseases, highlighting the importance of comprehensive drug reviews, patient-centered decision-making, and the need to include pregnant patients in clinical trials. Masu.
Lloyd Miller, MD: Detailed examination of JNJ-2113 data on plaque psoriasis
Miller, vice president and immunodermatology disease leader at Johnson & Johnson, spoke to Dermatology Times about recently published data supporting JNJ-2113’s potential in this indication.
John Barbieri, MD, MBA, FAAD: Statement of Evidence-Based Recommendations and Good Practices from the AAD Acne Guidelines
Barbieri spoke with Dermatology Times to discuss the new guidelines and the recommendations and good practice statements they contain.
First U.S. consensus on unified nomenclature and diagnosis of neuropathic pruritus announced
Dr. Shawn Kwatra shares insights into the debilitating impact that neuropathic pruritus has on patients and how clinicians can use a uniform nomenclature.
Improving skin color expression in dermatology
FAAD’s Dr. Miranda Uzoma Ewerkwa reviews how skin color representation has evolved in dermatology, but further advocacy is still needed.
Platelet-rich plasma for hair repair and skin rejuvenation: benefits recognized but consensus needed
Platelet-rich plasma (PRP) holds great promise for hair and skin regeneration applications, but testing, standards and protocols are needed, a review has found.
Don’t miss a moment Dermatology Times By signing up to electronic newsletter Subscribe to receive free print issues and supplements monthly.